亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

  • Imbruvica, Rituxan Combination sNDA Accepted for Review by FDA americanpharmaceuticalreview
    June 27, 2018
    AbbVie announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a supplemental New Drug Application (sNDA) for Imbruvica (ibrutinib) in combination with rituximab (Rituxan) as a new treatment option for Waldenstr?m's macroglo
PharmaSources Customer Service